1. Home
  2. Pharma and Healthcare

Category: Pharma and Healthcare

Sagard NewGen backs Laboratoires Delbert

Sagard NewGen has taken part in a €40m investment for French pharmaceuticals company Laboratoires Delbert.

Amadeus Capital Partners eyes LatAm tech growth, European scale-ups with new partner hires

Global technology investor Amadeus Capital Partners has hired two new partners and a healthcare analyst in a major expansion of its investment team.

Sagard NewGen holds first close for €300m first fund

French private equity firm Sagard NewGen has held a first closing for its debut fund, which focuses on the European healthcare and technology industries.

Sagard launches new European small-cap fund targeting healthcare, tech deals

Alternative asset manager Sagard Holdings has launched a new European small-cap fund focused on the healthcare and technology sectors.

Pandemic-resilient Chinese healthcare companies in Investcorp’s sights with launch of new platform

Alternative investment major Investcorp has launched a new platform dedicated to backing Chinese healthcare companies.

LLCP Buys Tropical Smoothie from BIP

Levine Leichtman Capital Partners (LLCP) has acquired Tropical Smoothie Café from BIP Capital in partnership with the company’s management team. Tropical Smoothie Café (TSC) is a franchisor of fast-casual cafes that serve smoothies, wraps, sandwiches,

Kilroy Buys Cheeze Kurls

Private label and contract food manufacturer Cheeze Kurls has been acquired by Kilroy Partners. Cheeze Kurls’ products include extruded, fried, and baked products as well as popcorn and party mixes which are sold to retail,

Now We Know Some Stuff

By Andy Greenberg, CEO GF Data and Greenberg Variations Capital Back in April, I wrote a commentary titled “Nobody Knows Anything” that described the immediate challenges facing the M&A industry in the wake of a

AMoon leads £23m series-A for Mina Therapeutics

AMoon has led a £23m series-A for RNA activation therapeutics company Mina Therapeutics.

China Resources’ property manager pre-markets $1bn HK IPO

China Resources Mixc Lifestyle Services has begun testing investor appetite for its Hong Kong listing, which could raise around $1bn, said a source close to the deal.

Antengene targets HK$2.8bn from Hong Kong IPO

Antengene Corp, a clinical stage biopharmaceutical company, has set its Hong Kong listing in motion. It has opened bookbuilding for an up to HK$2.79bn ($359.4m) IPO.

Berkshire Launches El Dorado Foods

Berkshire Partners has partnered with food executive Javier Vélez-Bautista to form El Dorado Foods. Mr. Vélez-Bautista now becomes the CEO of El Dorado and the new platform will be active acquiring Latin-inspired food and beverage

China policy and markets round-up: Beijing joins WHO-led vaccine initiative, September forex reserves drop, Trump resumes China Covid blame

In this round-up, China joins an initiative backed by the World Health Organization for fair global access to Covid-19 vaccines, the country’s foreign exchange reserves slide, and US president Donald Trump continues blaming Beijing for

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.